1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Partial atrioventricular canal: new trials by email Literature Review of Partial atrioventricular canal trials Research Report on Partial atrioventricular canal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects L-citrulline, Plasmalyte A - Ventricular Septal Defect, Atrioventricular Septal Defect | Phase 3 | Terminated | Asklepion Pharmaceuticals, LLC | 64 | 2022-06-29 | 2024-09-19 |
Atrioventricular Septal Defect (1) · Heart Septal Defects, Ventricular (1)
Cardiovascular Abnormalities (1) · Cardiovascular Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Heart Defects, Congenital (1) · Heart Diseases (1) · Heart Septal Defects (1)
Citrulline (1) · Plasmalyte A (1)
Asklepion Pharmaceuticals, LLC (1)
United States (1)
Christopher Mastropietro, MD, FCCM (1) · Gurdyal Kalsi, MD, MFPM (1)